MR&3D Local: Mixed Reality Technique Combined With 3D Printing Navigational Template for Localizing Pulmonary Nodules

Sponsor
Wen-zhao ZHONG (Other)
Overall Status
Unknown status
CT.gov ID
NCT04552054
Collaborator
Guangdong Provincial People's Hospital (Other)
136
1
2
31
4.4

Study Details

Study Description

Brief Summary

This study evaluates the viability and accuracy of preoperative mixed reality technique combined with three-dimensional printing navigational template guided localizing pulmonary small nodules.

Condition or Disease Intervention/Treatment Phase
  • Device: Mixed Reality+ 3D printing guided localization
  • Device: Computerized Tomography guided localization
N/A

Detailed Description

Pulmonary wedge resection is one of the most common types of operations performed by thoracic surgeons, especially given that more and more patients with ground glass nodules are being detected recently. One of the most significant current discussion concerning wedge resection is nodule localization. At present, a commonly used localization method is the CT-guided percutaneous lung puncture methylene blue staining marker localization, but this method has two main disadvantages: 1. the methylene blue dye is easy to spread, affecting the intraoperative judgment of nodule position by surgeon; 2. patients often suffer additional CT radiation. Mixed reality (MR) technique aims to enhance the simple self-visual effect and facilitate visualization of the surrounding environment in any situation. The three-dimensional model can be visualized by MR technique through MR glasses. Investigators project a three-dimensional reconstructed image of the patient's chest through MR glasses, then overlay the virtual chest with the actual chest, and then use this as a guide for percutaneous lung puncture localization. At the same time, investigators design an three-dimensional printing navigational template based on the 3D reconstruction model and place it on the surface of the body to help to guide the localization. This study is designed to evaluates the viability and accuracy of preoperative mixed reality technique combined with 3D printing navigational template guided localizing pulmonary nodules.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
136 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Preoperative Mixed Reality Technique Combined With Three-Dimensional Printing Navigational Template Guided Localizing Pulmonary Small Nodules : a Prospective, Unicenter, Randomized Study.
Actual Study Start Date :
May 1, 2018
Anticipated Primary Completion Date :
Oct 31, 2020
Anticipated Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: CT guided localization

Computerized Tomography(CT)-guided percutaneous lung puncture staining marker localization

Device: Computerized Tomography guided localization
CT-guided percutaneous lung puncture staining marker localization.

Experimental: MR+3D guided localization

Mixed reality(MR)+3D printing-guided percutaneous lung puncture staining marker localization

Device: Mixed Reality+ 3D printing guided localization
Researchers project a three-dimensional reconstructed image of the patient's chest through MR glasses, then overlay the virtual chest with the actual chest. Finally, researchers put the three-dimensional printing navigational template on the surface of the body to guide for percutaneous lung puncture localization.

Outcome Measures

Primary Outcome Measures

  1. Puncture success rate of localization [During surgery]

    The deviations of less than 2 cm between the lesion and the injected site was defined as successful localization.

Secondary Outcome Measures

  1. Time of localization [During surgery]

    To evaluate the time of the localization in each groups. The investigators record the start and end time of localization respectively.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • a maximum target lung nodule (one or more) diameter ≤20 mm

  • a target nodule CTR <0·25 or a minimum distance from the outer edge of the nodule to the nearest pleural surface >10 mm if the target nodule CTR was >0·25.

  • Plan to perform VATS lung wedge resection

Exclusion Criteria:
  • Inability to comply with research protocols or research procedures

  • Any unstable systemic disease (including active infections, uncontrolled high blood pressure, unstable angina, angina pectoris that has started within the last 3 months, congestive heart failure (≥ New York Heart Association [NYHA] Level II ), cardiac infarction (6 months before enrollment), severe arrhythmia requiring medication, liver, kidney or metabolic disease

  • Active bleeding; Inability to withstand lying flat; Inability to cooperate through breathing during puncture

  • Pregnant or lactating women

  • Other circumstances that the investigator believes are not suitable for enrollment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Guangdong Provincial People's Hospital Guangzhou Guangdong China 51000

Sponsors and Collaborators

  • Wen-zhao ZHONG
  • Guangdong Provincial People's Hospital

Investigators

  • Principal Investigator: Wen-Zhao Zhong, Ph.D, Guangdong Provincial People's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wen-zhao ZHONG, Principal Investigator, Guangdong Provincial People's Hospital
ClinicalTrials.gov Identifier:
NCT04552054
Other Study ID Numbers:
  • 46783912
First Posted:
Sep 17, 2020
Last Update Posted:
Sep 17, 2020
Last Verified:
May 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Wen-zhao ZHONG, Principal Investigator, Guangdong Provincial People's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 17, 2020